COSCIENS Biopharma Inc
NASDAQ:CSCI

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
NASDAQ:CSCI
Watchlist
Price: 2.15 USD -29.28% Market Closed
Market Cap: 8.1m USD

Operating Margin

-92.1%
Current
Improving
by 92.7%
vs 3-y average of -184.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-92.1%
=
Operating Income
$-11.6m
/
Revenue
$9.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-92.1%
=
Operating Income
$-11.6m
/
Revenue
$9.1m

Peer Comparison

Country Company Market Cap Operating
Margin
CA
COSCIENS Biopharma Inc
TSX:CSCI
9.7m CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.5B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
No Stocks Found

Market Distribution

Lower than 73% of companies in Canada
Percentile
27th
Based on 4 855 companies
27th percentile
-92.1%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

COSCIENS Biopharma Inc
Glance View

Market Cap
8.1m USD
Industry
Biotechnology

COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

CSCI Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-92.1%
=
Operating Income
$-11.6m
/
Revenue
$9.1m
What is COSCIENS Biopharma Inc's current Operating Margin?

The current Operating Margin for COSCIENS Biopharma Inc is -92.1%, which is above its 3-year median of -184.9%.

How has Operating Margin changed over time?

Over the last 3 years, COSCIENS Biopharma Inc’s Operating Margin has increased from -160% to -92.1%. During this period, it reached a low of -295.5% on Mar 31, 2023 and a high of -48.9% on Dec 31, 2023.

Back to Top